Research Appraisaldiagnostic

Optimizing machine learning-based diagnosis of neurosyphilis in HIV-negative patients: a multicenter, real-world comparison of international diagnostic criteria

Emerging microbes & infectionsJiang, Yinbo, Deng, Xinlei, Zhang, Xiaohui et al.1 Dec 2026DOI

Clinical Snapshot

80CEBM
Evidence: Moderatediagnostic

PICO Framework

P — PopulationHIV-negative patients with suspected neurosyphilis from four international centers (Guangzhou, Beijing, Xiamen, Seattle)
I — InterventionMachine learning diagnostic models based on six international diagnostic guidelines
C — ComparatorTraditional diagnostic approaches using international criteria without ML enhancement
O — OutcomesDiagnostic accuracy metrics (AUC, PRAUC, sensitivity, specificity), calibration, clinical utility via decision curve analysis

Bottom Line

This multicenter study developed machine learning models for neurosyphilis diagnosis in HIV-negative patients, achieving excellent discrimination (AUC >0.90) across six international diagnostic guidelines. The models consistently identified neurological symptoms, CSF protein, and CSF white blood cell count as key predictors. External validation across diverse geographic settings (China and USA) demonstrated robust performance with good calibration and positive clinical utility. The freely available web-based tool offers significant potential to improve diagnostic accuracy, particularly in resource-limited settings where specialist expertise and comprehensive CSF testing may be unavailable. However, the abstract lacks specific sensitivity/specificity values and confidence intervals, limiting full assessment of clinical utility. The approach addresses a critical diagnostic challenge in infectious diseases, though clinicians should await full publication details before implementation.

Evidence: Moderate

Key Findings

  • P Value: Not reported in abstract

  • Effect Size: AUC and PRAUC >0.90 for all models

  • Primary Outcome: Diagnostic accuracy across six international guidelines using machine learning models

  • Nnt Or Sensitivity: Sensitivity and specificity values not specified in abstract, though excellent discrimination (AUC >0.90) suggests high diagnostic accuracy

  • Confidence Interval: Not reported in abstract

Clinical Application

High feasibility with free web-based tool requiring only basic clinical and CSF parameters Highly relevant for Australian practice given rising neurosyphilis rates; tool could support rural and remote clinicians with limited access to specialist expertise; aligns with RACGP emphasis on evidence-based diagnostic support tools HIV-negative patients with suspected neurosyphilis in both resource-rich and resource-limited healthcare settings

Abstract

Neurosyphilis continues to rise globally, yet diagnosis remains challenging, often requiring multidisciplinary expertise and multiple CSF assays that are difficult to access in resource-limited settings. We developed and compared machine-learning (ML) models tailored to six international diagnostic guidelines and built a free, web-based tool for guideline-adapted decision support. We assembled 1,648 suspected neurosyphilis cases from four centers, using Guangzhou as the training cohort and Beijing, Xiamen (China) and Seattle (USA) as external validation cohorts. Five algorithms (Random Forest, AdaBoost, SVC, NuSVC, XGBoost) were trained with randomized search and three-fold cross-validation; performance was assessed by AUC, PRAUC, calibration, decision-curve net benefit, Brier score, and SHAP for model explainability. Across models and guidelines, neurological symptoms, CSF protein, and CSF white blood cell count consistently ranked as the strongest predictors. All models achieved excellent discrimination (AUC and PRAUC >0.90) with good calibration, reliability, and positive clinical utility, though performance varied modestly by guideline. These findings indicate that the optimal ML approach depends on the diagnostic definition applied. Our freely available online tool operationalizes these models to provide clinicians worldwide with context-adapted support aligned to local criteria.

Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service